Synergy Healthcare focuses on advancing clinical research and care across a broad range of cardiometabolic, hepatic, and pulmonary conditions. Our core areas include metabolic liver diseases such as NASH/MASH (including F2–F4 fibrosis), MASLD, and liver cirrhosis; chronic respiratory diseases including COPD (moderate to severe); and gastrointestinal and inflammatory conditions such as ulcerative colitis. We also support research in complex and multi-system conditions, including heart failure and related cardiometabolic disorders. In alignment with evolving standards of care, we are expanding our focus on obesity and metabolic health, including the integration of GLP-1–based therapies and comprehensive weight management strategies. Through this approach, we aim to improve patient outcomes by addressing the interconnected drivers of chronic disease.
About Synergy
Dr. Patrick Weston
Dr. Weston, an internist and cardiologist, serves as the co-founder and CEO of Synergy Healthcare. He earned his Bachelor of Science degree from Pennsylvania State University before pursuing his Doctor of Medicine (M.D.) from the University of Pittsburgh School of Medicine.
Dr. Weston further enriched his expertise with an MBA from the Northwestern Kellogg School of Management. Commencing his research journey at the Duke Clinical Research Institute, he specialized in cardiovascular research, amassing over 20 years of invaluable clinical research experience.
Most recently Dr. Weston has led metabolic clinical research including NASH/NAFLD, Fatty Liver, Diabetes, Hypertension, Cirrhosis and more.
Mission Statement
At Synergy Healthcare, we unite providers, communities, and researchers to advance access to innovative, personalized care. Through leading clinical research and strong partnerships, we break down barriers, promote inclusivity, and improve health outcomes for all.
Community Involvement
